首页> 外文期刊>Journal of Clinical Epidemiology >Empirical comparison of the results of randomized controlled trials and case-control studies in evaluating the effectiveness of screening mammography.
【24h】

Empirical comparison of the results of randomized controlled trials and case-control studies in evaluating the effectiveness of screening mammography.

机译:随机对照试验和病例对照研究评估乳腺钼靶筛查效果的实证比较。

获取原文
获取原文并翻译 | 示例
           

摘要

The gold standard for evaluating screening programs is the randomized controlled trial (RCT). Case-control studies are easier to perform but their role in this area is controversial. The purpose of this article is to compare empirically the results of RCTs and case-control studies conducted to evaluate the efficacy and effectiveness of screening mammography and examine possible explanations for differences in their results. We located eight RCTs and five case-control studies of screening mammography. For women aged 40-74 years at screening, comparison of the summary risk estimates of the RCTs (0.76, 95% CI: 0.69-0.83) with that of the case-control studies (0.44, 95%, CI: 0.38-0.50) showed RCTs to have a significantly higher summary risk estimate than case-control studies (ratio = 1.74, 95% CI: 1.48-2.04). It is notable that the RCTs were compromised in most instances by low compliance rates (50-80%) in the treatment groups and by significant use of screening in the control groups (20-30%). Adjustment of the RCT results for these cross-overs yields results that are in reasonable agreement with the summary estimate for the case-control studies. These findings support the use of case-control studies to estimate the efficacy of mammographic screening where RCTs are not feasible. They suggest that the efficacy of mammography in women aged 50 years and above is somewhat greater than the effectiveness measured by the intent-to-treat analysis of RCTs.
机译:评估筛查程序的金标准是随机对照试验(RCT)。病例对照研究较容易进行,但在这一领域的作用尚存争议。本文的目的是从经验上比较随机对照试验和病例对照研究的结果,以评估乳腺钼靶筛查的有效性和有效性,并检查其结果差异的可能解释。我们找到了8个随机乳腺摄影RCT和5个病例对照研究。对于筛查年龄在40-74岁之间的女性,将RCT的汇总风险评估(0.76,95%CI:0.69-0.83)与病例对照研究的风险评估(0.44,95%,CI:0.38-0.50)进行比较结果显示,RCT的汇总风险估算值明显高于病例对照研究(比率= 1.74,95%CI:1.48-2.04)。值得注意的是,在大多数情况下,治疗组的依从率低(50-80%)和对照组的筛查大量使用(20-30%)损害了RCT。对这些交叉的RCT结果进行调整,得出的结果与病例对照研究的摘要估算值合理地吻合。这些发现支持使用病例对照研究来评估无法进行RCT的乳腺X线摄影筛查的有效性。他们认为,乳腺X线摄影术对50岁及50岁以上女性的疗效要比RCT的意向治疗分析所测得的疗效更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号